From Essential obstetric and newborn care › Chapter 2: Bleeding during the first half of pregnancy · Médecins Sans Frontières, Current online edition, 2026
Clinical guidance on diagnosis and management of spontaneous and induced abortion before 22 weeks for healthcare providers in resource-limited settings.
- Issuer
- Médecins Sans Frontières
- Edition
- Current online edition, 2026
- Audience
- Healthcare providers in resource-limited settings providing obstetric care
- Evidence
- Expert consensus based on IPAS and WHO technical guidance
- Reviewed
- 23 Oct 2026 · GMJ
What this guideline says
GMJ summary
This section of the MSF Essential Obstetric and Newborn Care guideline provides comprehensive clinical guidance on managing abortion (spontaneous miscarriage or induced termination) occurring before 22 weeks of pregnancy. The guideline emphasises that in countries with legal restrictions, unsafe induced abortions performed under poor conditions often lead to life-threatening complications including trauma, bleeding, and severe infection.
The document covers diagnosis of threatened, missed, incomplete, and septic abortion, with differential diagnoses including ectopic pregnancy and cervical pathology. Management strategies are differentiated by gestational age (before or after 13 weeks) and clinical presentation, offering both medical management with misoprostol (with or without mifepristone) and instrumental evacuation options. The guideline prioritises manual vacuum aspiration over sharp curettage as less traumatic and painful.
Special attention is given to septic abortion management, requiring immediate antibiotic therapy and uterine evacuation regardless of gestational age, with specific dosing regimens for amoxicillin/clavulanic acid, gentamicin, ampicillin, and metronidazole. Precautions for patients with previous uterine scars, grand multiparity, or uterine overdistention include reduced misoprostol doses and close monitoring for uterine rupture.
Key points
For clinicians — doses and thresholds as stated in the guideline
- Missed abortion before 13 weeks: misoprostol 600 micrograms sublingually or 800 micrograms vaginally, repeat every 3 hours if needed (maximum 3 doses total), or manual vacuum aspiration
- Missed abortion 13–22 weeks: mifepristone 200 mg PO followed 1–2 days later by misoprostol 400 micrograms every 4–6 hours, or misoprostol alone at the same dose
- Incomplete abortion before 13 weeks: manual vacuum aspiration preferred, or misoprostol 400 micrograms sublingually or 600 micrograms PO single dose
- Incomplete abortion 13–22 weeks: misoprostol 400 micrograms sublingually every 3 hours until expulsion; instrumental evacuation if haemorrhage present
- Patients with ≥2 previous uterine scars, grand multiparity, or uterine overdistention: reduce misoprostol to 200 micrograms every 6 hours and monitor closely for uterine rupture
- Septic abortion: immediate antibiotics (amoxicillin/clavulanic acid 1 g IV every 8 hours plus gentamicin 5 mg/kg IM once daily, or triple therapy with ampicillin, metronidazole, and gentamicin) and urgent uterine evacuation
- Continue IV antibiotics until fever resolves (minimum 48 hours), then complete 5 days with oral therapy; treat very severe infections for 10 days
- Manual vacuum aspiration under local anaesthesia is the method of choice for instrumental evacuation: technically easier, less traumatic, and less painful than curettage
Tetanus prophylaxis
Table extracted from the guideline
| Immunisation status | Spontaneous abortion | Unsafe abortion with wound or foreign bodies |
|---|---|---|
| Not immunised or immunisation status unknown | Begin immunisation against tetanus | Begin immunisation against tetanus + Human tetanus immune globulin |
| Incompletely immunised | Tetanus booster | Tetanus booster + Human tetanus immune globulin |
| Fully immunised: last booster < 5 years | No prophylaxis | No prophylaxis |
| Fully immunised: last booster 5–10 years | No prophylaxis | Tetanus booster |
| Fully immunised: last booster > 10 years | Tetanus booster | Tetanus booster + Human tetanus immune globulin |
Source: Médecins Sans Frontières, Abortion — MSF Essential obstetric and newborn care. Reproduced in summary form.
From the guideline
Verbatim
“Aspiration under local anaesthesia is the method of choice. It is technically easier to perform, less traumatic and less painful than curettage.”
Editor’s perspective
Why this matters for Georgia and the region
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, Georgian Medical Journal · Chair, Public Health Institute of Georgia · WHO consultant, health and migration
As someone who has worked extensively on maternal health in Georgia and the region, I recognise that post-abortion care remains a critical gap in our health systems, regardless of legal frameworks around termination. The MSF guideline's emphasis on manual vacuum aspiration over sharp curettage addresses a persistent practice pattern in many of our facilities where the older technique still predominates, despite being more traumatic. I would particularly stress to Georgian clinicians the reduced misoprostol dosing protocols for women with previous caesarean scars—highly relevant given our caesarean rates exceed 40% in some regions—and the importance of immediate antibiotic initiation before evacuation in septic cases. The main implementation challenge will be ensuring consistent availability of misoprostol in appropriate formulations and manual vacuum aspiration equipment in district-level facilities, alongside training programmes that update provider skills beyond traditional curettage techniques to evidence-based approaches.
ORCID 0000-0001-7609-4515 · Perspective written for the GMJ Guidelines Library, 23 Oct 2026
Applicability
Georgia and the South Caucasus
This guideline is highly relevant for Georgia and the South Caucasus region, where access to safe abortion services varies and post-abortion care remains an essential component of maternal health services. Healthcare facilities must ensure availability of misoprostol, manual vacuum aspiration equipment, and appropriate antibiotics for septic complications. National programmes should consider training healthcare providers in manual vacuum aspiration techniques as a safer alternative to sharp curettage, ensuring availability of blood screening for transfusions (HIV, hepatitis B and C, syphilis), and establishing protocols that comply with national abortion legislation while prioritising management of complications from unsafe procedures. The reduced misoprostol dosing for women with previous caesarean scars is particularly relevant given rising caesarean section rates in the region.
Questions this guideline answers
Quick answers
What is the difference between medical and instrumental management of incomplete abortion before 13 weeks?
Medical management uses misoprostol 400 micrograms sublingually or 600 micrograms orally as a single dose. Instrumental management uses manual vacuum aspiration (preferred) or curettage. Aspiration under local anaesthesia is technically easier, less traumatic, and less painful than curettage.
When should antibiotics be started for septic abortion?
Antibiotics should be administered as soon as possible in septic abortion, before performing uterine evacuation. Use amoxicillin/clavulanic acid 1 g IV every 8 hours plus gentamicin 5 mg/kg IM once daily, or triple therapy with ampicillin, metronidazole, and gentamicin. Continue IV therapy until fever disappears (minimum 48 hours), then switch to oral therapy to complete 5 days (10 days for very severe infections).
Why is misoprostol dosing different for women with previous caesarean scars?
Women with 2 or more previous uterine scars, grand multiparity, or uterine overdistention are at higher risk of uterine rupture. For these patients, reduce misoprostol to 200 micrograms every 6 hours (instead of 400 micrograms), preferably use mifepristone combined with misoprostol (requires fewer doses), and closely monitor for signs of impending rupture including heart rate, blood pressure, uterine contractions, and pain.
What blood products need to be screened before transfusion for severe bleeding?
Before transfusion, blood must be screened for HIV-1, HIV-2, hepatitis B, hepatitis C, syphilis, and malaria in endemic areas. Patient blood type should be determined and potential donors selected or blood availability ensured before transfusion becomes necessary.
Related on GMJ
Interconnected resources
Dictionary of Public Health
Drugs A–Z
GMJ News coverage
Quality & accreditation
Same guideline
- Monitoring complicated pregnancies — MSF Essential obstetric and newborn careChapter 1: Diagnosing and monitoring pregnancy
- Antenatal consultations — MSF Essential obstetric and newborn careChapter 1: Diagnosing and monitoring pregnancy
- Diagnosing pregnancy — MSF Essential obstetric and newborn careChapter 1: Diagnosing and monitoring pregnancy
Other guidelines on this topic
- Monitoring complicated pregnancies — MSF Essential obstetric and newborn care
- Antenatal consultations — MSF Essential obstetric and newborn care
- Diagnosing pregnancy — MSF Essential obstetric and newborn care
- Priority indicators to monitor the impact of heat exposure on maternal, newborn and child health
- Special situations in multidrug-resistant and rifampicin-resistant tuberculosis treatment — MSF Tuberculosis
- Issuer
- Médecins Sans Frontières
- Guideline
- Essential obstetric and newborn care
- Chapter
- Chapter 2: Bleeding during the first half of pregnancy
- Type
- Clinical guideline (chapter)
- Edition
- Current online edition, 2026
- Status
- Current
- Published
- 2026-10-14
- Scope
- Before 22 weeks LMP
- Audience
- Healthcare providers in resource-limited settings providing obstetric care
- Evidence
- Expert consensus based on IPAS and WHO technical guidance
- Record history
- Created 23 Oct 2026 · updated 23 Oct 2026 · next check Apr 2027
Médecins Sans Frontières. Abortion. In: Essential obstetric and newborn care. Section 2.1. MSF; 2026. Available from: [URL]GMJ Guidelines Library records are original summaries written by the GMJ editorial team from the issuer’s published document and reviewed by a physician. They do not replace the full guideline. The document is the copyright of its issuer and is linked, not hosted. Spotted an error or a newer edition? Tell the Guidelines Desk.
Was this article helpful?

